% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Zitricky:293941,
      author       = {F. Zitricky and A. Koskinen and K. Sundquist and J.
                      Sundquist and V. Liska and A. Försti$^*$ and A. Hemminki
                      and K. Hemminki$^*$},
      title        = {{S}urvival in {T}hyroid {C}ancer in {S}weden {F}rom 1999
                      {T}o 2018.},
      journal      = {Clinical epidemiology},
      volume       = {16},
      issn         = {1179-1349},
      address      = {Albany, Auckland},
      publisher    = {Dove Medical Press},
      reportid     = {DKFZ-2024-02008},
      pages        = {659 - 671},
      year         = {2024},
      note         = {#LA:Z999#},
      abstract     = {Thyroid cancer (TC) is diagnosed in several histological
                      types which differ in their clinical characteristics and
                      survival. We aim to describe how they influence TC survival
                      in Sweden.Cancer data were obtained from the Swedish cancer
                      registry between years 1999 and 2018, and these were used to
                      analyze relative survival.Relative survival for all TC
                      improved when analyzed in 10-year periods, and female
                      survival improved more than male survival. Female survival
                      advantage appeared to be present also for specific
                      histological types, although case numbers were low for rare
                      types. Female 5-year relative survival for TC was $100\%$
                      for follicular, $95.1\%$ for oncocytic, $93.4\%$ for
                      papillary, $89.7\%$ for medullary, and $6.1\%$ for
                      anaplastic cancer. Among the clinical TNM classes, only T4
                      and M1 stages were associated with decreased survival
                      compared to T1-3 and M0. Anaplastic cancer presented most
                      often at high T and M1 stages, in contrast to other TC.
                      Curiously, the diagnostic age for anaplastic M1 patients was
                      lower than that for M0 patients. Both anaplastic and
                      medullary cancers did not show age-dependent increases in
                      the probability of metastases, in contrast to the main
                      histological types. This could indicate the presence of
                      several types of anaplastic and medullary cancers.The poor
                      survival for anaplastic TC is an extreme contrast to the
                      excellent survival of differentiated TC. As less than $20\%$
                      of anaplastic cancer patients survived one year, urgent
                      diagnosis and initiation of treatment are important.
                      Facilitated treatment pathways have been instituted in
                      Denmark resulting in improved survival. Anaplastic cancer
                      should be a target of a major research focus.},
      keywords     = {anaplastic cancer (Other) / metastasis (Other) / prognosis
                      (Other) / relative survival (Other) / trends (Other)},
      cin          = {B062 / HD01 / Z999},
      ddc          = {610},
      cid          = {I:(DE-He78)B062-20160331 / I:(DE-He78)HD01-20160331 /
                      I:(DE-He78)Z999-20160331},
      pnm          = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
      pid          = {G:(DE-HGF)POF4-313},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:39371051},
      pmc          = {pmc:PMC11456301},
      doi          = {10.2147/CLEP.S467874},
      url          = {https://inrepo02.dkfz.de/record/293941},
}